(Q30874806)

13 November 2017

Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study (English)

1 reference

central retinal vein occlusion

13 November 2017

1 reference

1 reference

Glacet-Bernard A

1

1 reference

13 November 2017

Kuhn D

2

1 reference

13 November 2017

Vine AK

3

1 reference

13 November 2017

Oubraham H

4

1 reference

13 November 2017

Coscas G

5

1 reference

13 November 2017

Soubrane G

6

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

British Journal of Ophthalmology

13 November 2017

1 reference

13 November 2017

84

1 reference

13 November 2017

6

1 reference

13 November 2017

609-613

1 reference

Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.

13 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Treatment of postcataract fibrinous membranes with tissue plasminogen activator

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Viscosity and retinal vein thrombosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Occlusion of the retinal vein: anticoagulants and fibrinolytics (urokinase). Initial results of a randomized study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Prognostic factors for retinal vein occlusion: prospective study of 175 cases.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723517

Tissue plasminogen activator for postvitrectomy fibrin formation

25 November 2018

1 reference

12 December 2020

[Front-loading rt PA thrombolytic therapy in central or venous branch occlusions of the retina]

1 reference

12 December 2020

The use of tissue plasminogen activator in postvitrectomy cases

1 reference

12 December 2020

Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage

1 reference

12 December 2020

Surgical management of submacular hemorrhage. A series of 47 consecutive cases

1 reference

12 December 2020

Natural course of perfused central retinal vein occlusion

1 reference

12 December 2020

The management of central retinal vein occlusion

1 reference

12 December 2020

Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial

1 reference

12 December 2020

[Thrombolytic therapy with recombinant tissue-type plasminogen activator in patients with branch or central vein occlusion of the retina]

1 reference

12 December 2020

Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage

1 reference

12 December 2020

The natural course of central retinal vein occlusion

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.84.6.609

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

10837386

1 reference